• Not all wallets are equal, your reputation is now your collateral

    Introducing Cardano Credit Score, a wallet reputation engine that allows you to borrow without collateral.

    Want to see if your wallet makes the cut? Join the waitlist (link below) for access to our early lending pool with 1000 $ada

    How it works

    1โƒฃ Your on-chain activity (wallet age, balance, tx history, DAO participation etc) is scored 0-100 through a verifiable open-source algorithm.

    2โƒฃ Your score is minted as a Soulbound Token (SBT) tied to your wallet, accessible for smart contracts to read.

    3โƒฃ Smart contracts use it to determine loan eligibility, rates and limits.

    4โƒฃ Repay on time → increase your score. Default → decrease your score.

    This is huge for DeFi but it doesn't stop there.

    This trust layer is scalable across multiple verticals.

    AI Data Providers for trusted data.
    AI Agent reputations for reliable and secure interactions.
    DAO credibility metrics for governance and participation.
    Fairer access to any decentralized service.

    And more...

    Excited to take Cardano to the next level


    credit.nucast.io

    #Cardano #DEFI
    Not all wallets are equal, your reputation is now your collateral ๐Ÿ‘€ Introducing Cardano Credit Score, a wallet reputation engine that allows you to borrow without collateral. Want to see if your wallet makes the cut? Join the waitlist (link below) for access to our early lending pool with 1000 $ada How it works 1โƒฃ Your on-chain activity (wallet age, balance, tx history, DAO participation etc) is scored 0-100 through a verifiable open-source algorithm. 2โƒฃ Your score is minted as a Soulbound Token (SBT) tied to your wallet, accessible for smart contracts to read. 3โƒฃ Smart contracts use it to determine loan eligibility, rates and limits. 4โƒฃ Repay on time → increase your score. Default → decrease your score. This is huge for DeFi but it doesn't stop there. This trust layer is scalable across multiple verticals. โ˜‘๏ธ AI Data Providers for trusted data. โ˜‘๏ธ AI Agent reputations for reliable and secure interactions. โ˜‘๏ธ DAO credibility metrics for governance and participation. โ˜‘๏ธFairer access to any decentralized service. And more... Excited to take Cardano to the next level ๐Ÿš€ ๐Ÿ‘‡ ๐Ÿ”— credit.nucast.io #Cardano #DEFI
    Like
    3
    0 Comments 0 Shares 1K Views 0 Reviews
  • $RCAT
    Red Cat Holdings Balance Sheet Summary

    Financial Status
    The company reported quarterly revenue of $3.2 million (down 50% year-over-year).
    Net loss of $13.3 million (up 63% year-over-year).
    Gross profit increased by 40% year-over-year to $375,000.
    Cash and receivables totaled $66.9 million at the end of the quarter.
    Inventory and deposits of $21 million are being prepared for production capacity.
    Loss per share was reported as $0.15.

    Operational Developments
    - TD3 LRP contract signed with the US Army: 690 SRR Black Widow drone systems will be delivered.
    - AS9100 certification received: Quality and safety standard in the defense industry.
    - Production partnership established with ESAero: Outsourced support will be provided for mass production. - Expansion into the USV (Uncrewed Surface Vessel) segment: Product diversity is increasing with naval vessels.

    Strategic Notes
    - The company's liquidity position is sufficient to provide more than 20 quarters of operational capital at its current revenue level.
    - The defense-focused transformation offers the potential to increase profitability with higher-margin contracts.
    - The expansion of the SRR budget for 2026 strengthens the forward-looking revenue outlook.
    $RCAT Red Cat Holdings Balance Sheet Summary ๐Ÿ’ฐ Financial Status The company reported quarterly revenue of $3.2 million (down 50% year-over-year). Net loss of $13.3 million (up 63% year-over-year). Gross profit increased by 40% year-over-year to $375,000. Cash and receivables totaled $66.9 million at the end of the quarter. Inventory and deposits of $21 million are being prepared for production capacity. Loss per share was reported as $0.15. ๐Ÿ›ก๏ธ Operational Developments - TD3 LRP contract signed with the US Army: 690 SRR Black Widow drone systems will be delivered. - AS9100 certification received: Quality and safety standard in the defense industry. - Production partnership established with ESAero: Outsourced support will be provided for mass production. - Expansion into the USV (Uncrewed Surface Vessel) segment: Product diversity is increasing with naval vessels. ๐Ÿ“Œ Strategic Notes - The company's liquidity position is sufficient to provide more than 20 quarters of operational capital at its current revenue level. - The defense-focused transformation offers the potential to increase profitability with higher-margin contracts. - The expansion of the SRR budget for 2026 strengthens the forward-looking revenue outlook.
    Like
    Love
    2
    0 Comments 0 Shares 1K Views 0 Reviews
  • $KULR
    KULR Technology Balance Sheet Summary;

    Financial Results
    - Revenue increased by 63% year-over-year to $3.97 million, the highest level in the company's history.
    - Net income was $8.14 million ($0.22 per share); a loss of $5.89 million was reported in the same period last year.
    - Product sales increased by 74% to $1.98 million.
    - Gross margin decreased to 18% (24% in the previous year), due to unexpected labor costs.
    - SG&A expenses increased by 51% to $6.94 million, and R&D expenses increased by 86% to $2.44 million.
    - Operating loss increased to $9.45 million.

    โ‚ฟ Bitcoin Strategy
    - The company holds 1,035 BTC, worth approximately $101 million.
    - BTC yield was reported as 291.2%. - A $20 million loan agreement was signed with Coinbase; it will be used for Bitcoin purchases.

    Operational Developments
    - Bitcoin mining capacity reached 750 PH/s; target 1.25 EH/s.
    - The K1S 500 XLT energy storage solution was delivered to customers for the space sector.
    - The K1G battery successfully passed ballistic resistance tests.
    - The pressure-resistant submarine battery was delivered to a strategic partner.

    New Technologies and Partnerships
    - A partnership was established with German Bionic; the 7th generation EXIA exoskeleton was introduced in North America.
    - Included in the Russell 3000 Index; institutional investor interest may increase.
    - An 8-for-1 reverse stock split was completed; as part of a market positioning strategy.
    $KULR KULR Technology Balance Sheet Summary; ๐Ÿ’ฐ Financial Results - Revenue increased by 63% year-over-year to $3.97 million, the highest level in the company's history. - Net income was $8.14 million ($0.22 per share); a loss of $5.89 million was reported in the same period last year. - Product sales increased by 74% to $1.98 million. - Gross margin decreased to 18% (24% in the previous year), due to unexpected labor costs. - SG&A expenses increased by 51% to $6.94 million, and R&D expenses increased by 86% to $2.44 million. - Operating loss increased to $9.45 million. โ‚ฟ Bitcoin Strategy - The company holds 1,035 BTC, worth approximately $101 million. - BTC yield was reported as 291.2%. - A $20 million loan agreement was signed with Coinbase; it will be used for Bitcoin purchases. โš™๏ธ Operational Developments - Bitcoin mining capacity reached 750 PH/s; target 1.25 EH/s. - The K1S 500 XLT energy storage solution was delivered to customers for the space sector. - The K1G battery successfully passed ballistic resistance tests. - The pressure-resistant submarine battery was delivered to a strategic partner. ๐Ÿค– New Technologies and Partnerships - A partnership was established with German Bionic; the 7th generation EXIA exoskeleton was introduced in North America. - Included in the Russell 3000 Index; institutional investor interest may increase. - An 8-for-1 reverse stock split was completed; as part of a market positioning strategy.
    0 Comments 0 Shares 2K Views 0 Reviews
  • MAG7 vs. S&P 493 – April 7 → August 12, 2025

    The market picture is clear: The big ones are carrying, the broad base is providing limited support. Here's an X-ray of the last 4.5 months

    MAG7 (AAPL, AMZN, GOOGL, META, MSFT, NVDA, TSLA)
    • Index Weight: ~35.4% (record high)
    • Performance: +10.7%
    • Earnings growth +28% in Q1, continued strong in Q2
    • Still priced in with the "AI + quality growth" narrative
    • Risk: High valuation → susceptibility to surprises

    S&P 493 (Remainder)
    • Performance: +4.1% (RSP index)
    • Breadth: 55% at 200-day moving average
    • Earnings growth, but above-index momentum is limited
    • Valuation is more reasonable → potential for "catch-up"

    Overall Index (S&P 500)
    • Performance: +8.3%
    • P/E: 22.1x → Above 5- and 10-year moving averages
    • Q2 earnings growth: 11.8% (mega-caps again the driving force)

    Reading:
    While the MAG7 rebounded ~35% from its April 7 lows, the broad base remains moderate. Most of the index's rise comes from giants. Concentration risk is high → the impact is disproportionate, both in the uptrend and downtrend.

    Tactical Recommendation:

    - Strengthen the Majors: Include companies with growing profits and strong balance sheets (excess cash) within the MAG7 in your main portfolio.

    - Layer the Rest: Add small-medium weightings to sectors (healthcare, select industrials, some defensive stocks) within the 493 whose earnings expectations have been revised upwards and whose prices remain reasonable.

    - Divide Risk: Don't concentrate your investment solely on giant stocks; Diversify with products like the equal-weight index (RSP) or the S&P 500 – Excluding Top 10 Stocks.

    - Follow the Macro: Fed interest rate decisions, inflation data, and global trade news can quickly change the direction of mega-cap stocks in particular.

    This is not investment advice, but for informational purposes only!!!
    #MAG7 #SP500 #Finance #StockMarket #Investment #Stocks #MarketAnalysis #Investor #BorsaIstanbul #NASDAQ #WallStreet #Economy #FinancialLiteracy #Index #InvestmentStrategy #Portfolio
    ๐Ÿ“Š MAG7 vs. S&P 493 – April 7 → August 12, 2025 The market picture is clear: The big ones are carrying, the broad base is providing limited support. Here's an X-ray of the last 4.5 months โฌ‡๏ธ ๐Ÿ”น MAG7 (AAPL, AMZN, GOOGL, META, MSFT, NVDA, TSLA) • Index Weight: ~35.4% ๐Ÿ“ˆ (record high) • Performance: +10.7% • Earnings growth +28% in Q1, continued strong in Q2 • Still priced in with the "AI + quality growth" narrative • Risk: High valuation → susceptibility to surprises ๐Ÿ”น S&P 493 (Remainder) • Performance: +4.1% (RSP index) • Breadth: 55% at 200-day moving average • Earnings growth, but above-index momentum is limited • Valuation is more reasonable → potential for "catch-up" ๐Ÿ”น Overall Index (S&P 500) • Performance: +8.3% • P/E: 22.1x → Above 5- and 10-year moving averages • Q2 earnings growth: 11.8% (mega-caps again the driving force) ๐Ÿ“Œ Reading: While the MAG7 rebounded ~35% from its April 7 lows, the broad base remains moderate. Most of the index's rise comes from giants. Concentration risk is high → the impact is disproportionate, both in the uptrend and downtrend. ๐Ÿ“Œ Tactical Recommendation: - Strengthen the Majors: Include companies with growing profits and strong balance sheets (excess cash) within the MAG7 in your main portfolio. - Layer the Rest: Add small-medium weightings to sectors (healthcare, select industrials, some defensive stocks) within the 493 whose earnings expectations have been revised upwards and whose prices remain reasonable. - Divide Risk: Don't concentrate your investment solely on giant stocks; Diversify with products like the equal-weight index (RSP) or the S&P 500 – Excluding Top 10 Stocks. - Follow the Macro: Fed interest rate decisions, inflation data, and global trade news can quickly change the direction of mega-cap stocks in particular. This is not investment advice, but for informational purposes only!!! #MAG7 #SP500 #Finance #StockMarket #Investment #Stocks #MarketAnalysis #Investor #BorsaIstanbul #NASDAQ #WallStreet #Economy #FinancialLiteracy #Index #InvestmentStrategy #Portfolio
    0 Comments 0 Shares 2K Views 0 Reviews
  • $HIMS
    Hims & Hers' Weight Loss Strategy Shakes Up Balance Sheet Metrics!

    Telehealth platform Hims & Hers surprised investors by missing Wall Street expectations for the first time, despite a 73% year-over-year increase in revenue to $544.8 million in the second quarter. This led to a 13% post-session drop in the stock.

    The primary reason behind this unexpected decline in figures is forced changes to the company's GLP-1 (weight loss) drug strategy. With the FDA's end of the semaglutide shortage, Hims was forced to change its sales model for more affordable generic GLP-1 drugs. This led to a decline in online GLP-1 revenue from $230 million in the first quarter to $190 million in the second quarter, and a decrease in average revenue per subscriber from $84 to $74.

    While the company achieved 31% year-over-year subscriber growth, reaching 2.4 million subscribers, uncertainties surrounding its GLP-1 strategy and developments such as the termination of its partnership with Novo Nordisk cast doubt on its growth narrative. Negative free cash flow is another concern. Hims & Hers will now attempt to navigate this challenging period by focusing on personalized GLP-1 therapies.
    $HIMS Hims & Hers' Weight Loss Strategy Shakes Up Balance Sheet Metrics! ๐Ÿ“‰ Telehealth platform Hims & Hers surprised investors by missing Wall Street expectations for the first time, despite a 73% year-over-year increase in revenue to $544.8 million in the second quarter. This led to a 13% post-session drop in the stock. The primary reason behind this unexpected decline in figures is forced changes to the company's GLP-1 (weight loss) drug strategy. With the FDA's end of the semaglutide shortage, Hims was forced to change its sales model for more affordable generic GLP-1 drugs. This led to a decline in online GLP-1 revenue from $230 million in the first quarter to $190 million in the second quarter, and a decrease in average revenue per subscriber from $84 to $74. While the company achieved 31% year-over-year subscriber growth, reaching 2.4 million subscribers, uncertainties surrounding its GLP-1 strategy and developments such as the termination of its partnership with Novo Nordisk cast doubt on its growth narrative. Negative free cash flow is another concern. Hims & Hers will now attempt to navigate this challenging period by focusing on personalized GLP-1 therapies.
    0 Comments 0 Shares 1K Views 0 Reviews
  • $LLY | Eli Lilly Q2'25 Financial Results

    Strong Growth, Deepening Pipeline
    Revenue: $15.56B (+38% YoY)
    Adjusted EPS: $6.31 (+61% YoY)
    Zepbound: $3.38B (+172%)
    Mounjaro: $5.20B (+68%)

    Zepbound and Mounjaro solidify Eli Lilly's leadership in the metabolic diseases segment, with this quarter's results demonstrating momentum for both prescription penetration and patient acceptance of these products.

    FY25 guidance revised upward:
    Revenue: $60–62B
    Adj. EPS: $21.75–$23.00

    Positive developments in the pipeline (Orforglipron, Jaypirca, Kisunla) present very strong catalysts that will support growth in the medium to long term.

    It also appears to be continuing its focus on innovation with the acquisitions of SiteOne and Verve Therapeutics and the Purdue collaboration.

    Comment:
    Eli Lilly is demonstrating not only strong sales growth but also a structural transformation. Supported by its leadership in the GLP-1 class, cardiometabolic protection data, and R&D investments, the pipeline offers a defensive and growth combination for long-term investors.

    #LLY #EliLilly #Balance Sheet #GLP1 #Zepbound #Mounjaro #HealthcareSector #StockAnalysis
    ๐Ÿ“Š $LLY | Eli Lilly Q2'25 Financial Results Strong Growth, Deepening Pipeline ๐Ÿ”น Revenue: $15.56B (+38% YoY) ๐ŸŸข ๐Ÿ”น Adjusted EPS: $6.31 (+61% YoY) ๐ŸŸข ๐Ÿ”น Zepbound: $3.38B (+172%) ๐Ÿ”น Mounjaro: $5.20B (+68%) ๐Ÿ’ก Zepbound and Mounjaro solidify Eli Lilly's leadership in the metabolic diseases segment, with this quarter's results demonstrating momentum for both prescription penetration and patient acceptance of these products. ๐Ÿ“Œ FY25 guidance revised upward: โ–ซ๏ธ Revenue: $60–62B โ–ซ๏ธ Adj. EPS: $21.75–$23.00 ๐Ÿ”ฌ Positive developments in the pipeline (Orforglipron, Jaypirca, Kisunla) present very strong catalysts that will support growth in the medium to long term. ๐Ÿ’ผ It also appears to be continuing its focus on innovation with the acquisitions of SiteOne and Verve Therapeutics and the Purdue collaboration. ๐Ÿ“ˆ Comment: Eli Lilly is demonstrating not only strong sales growth but also a structural transformation. Supported by its leadership in the GLP-1 class, cardiometabolic protection data, and R&D investments, the pipeline offers a defensive and growth combination for long-term investors. #LLY #EliLilly #Balance Sheet #GLP1 #Zepbound #Mounjaro #HealthcareSector #StockAnalysis
    0 Comments 0 Shares 2K Views 0 Reviews
  • $CELH | Celsius Holdings Q2 25 Earnings

    Revenue: $739.3M (Considered: $654.3M) +84% YoY
    EPS (Adjusted): $0.47 (Considered: $0.24) +68% YoY
    EBITDA: $210.3M +109% YoY

    US Ready-to-Energy Drink Market Share: 17.3% (+180bps)
    CELSIUS: 11% (-130bps)
    Alani Nu: 6.3% (+310bps)

    Retail Sales Growth (YoY):
    CELSIUS: +3%
    Alani Nu: +129%
    Total Portfolio: +29%

    Revenue Breakdown:
    North America: $714.5M (+87%)
    International: $24.8M (+27%)

    CEO: We're shaping the category with Celsius and Alani Nu. Sugar-free, functional energy is our responsibility!

    #CELH #Earnings #Celsius #AlaniNu #EnergyDrink #BalanceSheet #FinancialData #Investment
    ๐Ÿ“Š $CELH | Celsius Holdings Q2 25 Earnings ๐Ÿ”ฅ ๐Ÿš€ Revenue: $739.3M (Considered: $654.3M) ๐ŸŸข +84% YoY ๐Ÿ’ต EPS (Adjusted): $0.47 (Considered: $0.24) ๐ŸŸข +68% YoY ๐Ÿ“ฆ EBITDA: $210.3M โž• +109% YoY ๐Ÿ“ˆ US Ready-to-Energy Drink Market Share: 17.3% (+180bps) โ–ซ๏ธ CELSIUS: 11% (-130bps) โ–ซ๏ธ Alani Nu: 6.3% (+310bps) ๐Ÿ›’ Retail Sales Growth (YoY): โ–ซ๏ธ CELSIUS: +3% โ–ซ๏ธ Alani Nu: +129% โ–ซ๏ธ Total Portfolio: +29% ๐ŸŒŽ Revenue Breakdown: โ–ซ๏ธ North America: $714.5M (+87%) โ–ซ๏ธ International: $24.8M (+27%) ๐ŸŽฏ CEO: We're shaping the category with Celsius and Alani Nu. Sugar-free, functional energy is our responsibility! #CELH #Earnings #Celsius #AlaniNu #EnergyDrink #BalanceSheet #FinancialData #Investment
    0 Comments 0 Shares 1K Views 0 Reviews
  • $U | Unity Q2 2025 Earnings Summary

    Revenue: $440.9M (expected $426.7M)
    → However, -2% YoY contraction
    Adj. EPS: $0.18 (expected -$0.28)

    Q2 Segment Details:
    Create Solutions: $154M (+2% YoY)
    Grow Solutions: $287M (-4% YoY)
    Unity Ad Network: +15% QoQ → 49% of the Grow segment

    Q3 Guidance:
    Revenue: $440M–$450M (expected $445.1M)
    Adj. EBITDA: $90M–$95M
    "Grow" segment: Mid-single-digit quarterly growth expected
    "Create" segment: Slight contraction expected

    Operational Data:
    Adj. EBITDA: $90M (21% margin)
    Free Cash Flow: $127M (previously $80M)
    Net Operating Cash: $133M (previously $88M)
    Cash & Cash Equivalents: $1.70B ($1.53B in December 2024)

    CEO Matt Bromberg:
    This quarter is a turning point for Unity. Our Unity Vector strategy is reshaping our growth potential. We surpassed the upper bounds in both revenue and EBITDA.

    Comment:
    Unity delivered a strong positive surprise in EPS and EBITDA, but annual revenue remains negative. The growth side is declining, but the ad network's recovery is positive. The create side is experiencing stable but limited growth. There is a significant improvement in cash flow, and the balance sheet is becoming more resilient.

    The "Unity Vector" strategy may herald a transformation.
    Limited growth in the short term, with a more aggressive recovery possible in the medium term.
    Margins are strong, and operational efficiency is improving.

    Unity is still in transition, but signs of a bottoming out are becoming clear.

    #Unity #U #Earnings #GameDev #AdTech #Q22025 #TechStocks #TradersPub #Investment #BalanceSheetAnalysis
    ๐ŸŽฎ $U | Unity Q2 2025 Earnings Summary ๐Ÿ”น Revenue: $440.9M (expected $426.7M) โœ… → However, -2% YoY contraction ๐Ÿ”น Adj. EPS: $0.18 (expected -$0.28) โœ… ๐Ÿ“Š Q2 Segment Details: ๐Ÿ”ธ Create Solutions: $154M (+2% YoY) ๐Ÿ”ธ Grow Solutions: $287M (-4% YoY) ๐Ÿ”ธ Unity Ad Network: +15% QoQ → 49% of the Grow segment ๐Ÿ“ˆ Q3 Guidance: ๐Ÿ”น Revenue: $440M–$450M (expected $445.1M) โž– ๐Ÿ”น Adj. EBITDA: $90M–$95M ๐Ÿ”น "Grow" segment: Mid-single-digit quarterly growth expected ๐Ÿ”น "Create" segment: Slight contraction expected ๐Ÿ’ฐ Operational Data: ๐Ÿ”น Adj. EBITDA: $90M (21% margin) ๐Ÿ”น Free Cash Flow: $127M (previously $80M) ๐Ÿ”น Net Operating Cash: $133M (previously $88M) ๐Ÿ”น Cash & Cash Equivalents: $1.70B ($1.53B in December 2024) ๐Ÿ—ฃ๏ธ CEO Matt Bromberg: This quarter is a turning point for Unity. Our Unity Vector strategy is reshaping our growth potential. We surpassed the upper bounds in both revenue and EBITDA. ๐Ÿ“Œ Comment: Unity delivered a strong positive surprise in EPS and EBITDA, but annual revenue remains negative. The growth side is declining, but the ad network's recovery is positive. The create side is experiencing stable but limited growth. There is a significant improvement in cash flow, and the balance sheet is becoming more resilient. ๐Ÿ”ธ The "Unity Vector" strategy may herald a transformation. ๐Ÿ”ธ Limited growth in the short term, with a more aggressive recovery possible in the medium term. ๐Ÿ”ธ Margins are strong, and operational efficiency is improving. Unity is still in transition, but signs of a bottoming out are becoming clear. #Unity #U #Earnings #GameDev #AdTech #Q22025 #TechStocks #TradersPub #Investment #BalanceSheetAnalysis
    Like
    1
    0 Comments 0 Shares 1K Views 0 Reviews